Neerman-Arbez M, de Moerloose P, Honsberger A, Parlier G, Arnuti B, Biron C, Borg J Y, Eber S, Meili E, Peter-Salonen K, Ripoll L, Vervel C, d'Oiron R, Staeger P, Antonarakis S E, Morris M A
Centre Médical Universitaire, Geneva, Switzerland.
Hum Genet. 2001 Mar;108(3):237-40. doi: 10.1007/s004390100469.
Congenital afibrinogenemia is an autosomal recessive disorder characterized by the complete absence of detectable fibrinogen. We previously identified the first causative mutations for this disease in a non-consanguineous Swiss family. These were homozygous deletions of approximately 11 kb of the fibrinogen alpha chain gene (FGA). Our subsequent study revealed that the majority of cases were attributable to truncating mutations in FGA, with the most common mutation affecting the donor splice site in FGA intron 4 (IVS4+1 G-->T). Here, we report 13 further unrelated patients with mutations in FGA, confirming the relative importance of this gene compared with FGG and FGB in the molecular aetiology of afibrinogenemia. Three other patients were homozygous for mutations in FGG. Eight novel mutations were identified: five in FGA and three in FGG. Sufficient mutation data is now available to permit an effective strategy for the genetic diagnosis of congenital afibrinogenemia.
先天性无纤维蛋白原血症是一种常染色体隐性疾病,其特征是完全检测不到纤维蛋白原。我们之前在一个非近亲瑞士家庭中鉴定出了该疾病的首个致病突变。这些突变是纤维蛋白原α链基因(FGA)约11 kb的纯合缺失。我们随后的研究表明,大多数病例归因于FGA中的截短突变,最常见的突变影响FGA内含子4(IVS4+1 G→T)中的供体剪接位点。在此,我们报告另外13例FGA发生突变的无亲缘关系患者,证实了该基因在无纤维蛋白原血症分子病因学中相对于FGG和FGB的相对重要性。另外3例患者FGG突变呈纯合状态。鉴定出8个新突变:5个在FGA中,3个在FGG中。现在已有足够的突变数据来制定先天性无纤维蛋白原血症的有效基因诊断策略。